Showing 352 articles in Pharma Appointments

  • Clinical Professionals, RIG Healthcare and Cpl Specialist Talent join forces to form to Cpl UK.

    28 Oct 2020| Nola Cadman

    Cpl is a global provider of talent solutions to startup companies, multinationals and SMEs in every sector from Pharmaceuticals to Fund Accounting. Founded in 1989, the Cpl Group now comprises 23 brands spanning more than 41 offices in 11 countries. Matching the right talent to the right organisation is the core guiding principle in everything we do.

  • Pharmiweb.Jobs Welcomes Vifor Pharma

    23 Oct 2020| Nola Cadman

    Vifor Pharma’s operational headquarters are in Zurich, Switzerland, and it has an increasingly global presence and a broad network of affiliates and partners around the world.

  • Allergan R&D Chief named as Chairman of Exscientia's Board of Directors

    21 Oct 2020| Nola Cadman

    David is a highly respected global R&D leader who brings a wealth of experience to the company as well as a strong US perspective

  • Maze Therapeutics has appointed Dr Sarah Noonberg as its Chief Financial Officer.

    21 Oct 2020| Nola Cadman

    Noonberg also serves on the Board of Directors at Protagonist Therapeutics and Neoleukin Therapeutics.

  • Dr Kevin Eggan named as Group Vice President, Head of Research and Early Development at BioMarin

    21 Oct 2020| Nola Cadman

    BioMarin Pharmaceutical has welcomed Dr Kevin Eggan as its new Group Vice President, Head of Research and Early Development. He took up to the position on 5 October.

  • ONK Therapeutics Closes New Financing and Appoints Chris Nowers as CEO

    21 Oct 2020| Nola Cadman

    ONK Therapeutics Ltd, is an innovative cell therapy company dedicated to developing a next generation of ‘off-the-shelf’, dual-targeted NK cell therapies targeting solid and hematological cancers.

  • DOCTOR CARE ANYWHERE WELCOMES ON BOARD COMMERCIAL DIRECTOR FROM KING EDWARD VII’s HOSPITAL TO DELIVER GROWTH PLANS

    21 Oct 2020| Nola Cadman

    Doctor Care Anywhere is a doctor-founded digital healthcare company. It is committed to delivering highquality, effective and efficient care to its patients, whilst reducing the overall cost of providing clinical services.

  • Gentronix Bolsters Executive Team To Drive Continued Growth

    20 Oct 2020| Mike Wood

    UK-based Contract Research Organisation (CRO) Gentronix – the largest independent genetic toxicology CRO in Europe - has appointed a new Operations Director to accelerate its strategic growth plans. 

  • BCW Appoints Achim Kautz as Senior Advisor

    14 Oct 2020| Mike Wood

    BCW, a leading global communications agency, today announced the appointment of Achim Kautz, a healthcare policy expert and patient advocate at global, European and national levels, as a Senior Advisor.

  • Almac Group Appoints Vice President of Small Molecule API

    7 Oct 2020| Mike Wood

    Almac Sciences, a member of the Almac Group, has announced the appointment of Dan Bayston as Vice President of Small Molecule API.

  • Lipidor strengthens management through strategic hire

    1 Oct 2020| Mike Wood

    Lipidor AB (Nasdaq First North: LIPI) today announces that the company is strengthening its management team through the recruitment of Anders Hagman as Chief Development Officer. Hagman will assume the role as of 1 October 2020.

  • Enesi Pharma Appoints Vaccine Development Expert Dr Keith Howard As Chief Scientific Officer to Lead Research & Development of Novel ImplaVax® Solid-dose, Needle-free Vaccination Products

    1 Oct 2020| Nola Cadman

    Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its world leading ImplaVax® technologies

  • VelosBio reveals new Chief Financial Officer

    25 Sep 2020| Nola Cadman

    Dr Enoch Kariuki has been named as the new Chief Financial Officer at biopharma firm VelosBio, where he will assume responsibility for the company’s finance-related and investor relations functions.

  • NovaGo Therapeutics appoints Ian Metcalfe as CEO

    25 Sep 2020| Nola Cadman

    Founded in 2015 in Schlieren, Switzerland, NovaGo Therapeutics is a development stage biotech company focused on human antibody therapeutics targeting blood vessel growth, nerve growth, and regeneration.

  • 4D pharma makes strategic appointment of independent Non-Executive Director in response to new clinical success and next stages of global development

    25 Sep 2020| Nola Cadman

    Founded in February 2014, 4D pharma is a world leader in the development of Live Biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacterium, that is applicable to the prevention, treatment or cure of a disease.

  • Dr. Jean-Christophe Rufin appointed President of the Sanofi Espoir Corporate Foundation

    18 Sep 2020| Nola Cadman

    Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

  • Exostar Adds CTO & CRO to Support Customers & Growth

    18 Sep 2020| Nola Cadman

    New CTO and CRO Bring Long Track Records of Building and Delivering Innovative, “Always-On” Enterprise-Class Solutions That Solve Mission-Critical Problems for Customers in Highly-Regulated Industries

  • Med-Tech enterprise TestCard makes four new senior appointments to its Board of Directors

    18 Sep 2020| Nola Cadman

    The four arrive at TestCard with decades of relevant corporate experience behind them.

  • Boyds bolsters clinical operations team with appointment of Kathryn Bartley

    18 Sep 2020| Nola Cadman

    Kathryn Bartley has joined as pharmaceutical and biotech product development consultancy Boyds as Senior Clinical Research Associate.